Overcoming time pressure and the global shortage of test kits and reagents, the 8-member Microbiology team from Gleneagles Hospital Hong Kong’s Clinical Laboratory has made in-house COVID-19 testing a reality, about two months after Hong Kong confirmed its first COVID-19 case.
Today, Gleneagles Hospital Hong Kong is capable of testing up to 150 COVID-19 samples daily in its laboratory. It uses two test platforms (POCT or point of care testing and PCR or polymerase chain reaction testing), to provide quality and efficient service to meet our patients’ needs.
Between end of March and end of May, the hospital tested more than 200 cases, while supporting the Hong Kong Government Department of Health’s Community Deep Throat Saliva Surveillance Programme with about 300 cases.
The team is ramping up the laboratory’s testing capacity to meet the anticipated surge in testing demand as the government prepares to open up its borders to businesses travellers with negative COVID-19 nucleic acid testing result certification.
By making COVID-19 testing available to our patients and the medical needs of our clinicians, Gleneagles Hospital Hong Kong is helping to stem the spread of the virus in the community. It is also keeping our hospital safe for our inpatients and frontline staff, ensuring that it continues to provide uninterrupted healthcare services during the COVID-19 pandemic.
Related Stories
Transforming Our Future: A Decade of Quality & Safety
The 10th IHH Healthcare Quality Summit 2025 in Hong Kong brought together more than 200 leaders, clinicians and quality champions from across our global network to reaffirm our commitment to clinical excellence, patient safety, and transformative care.
Pantai Hospital Kuala Lumpur Powers Malaysia’s Biggest Marathon with Heart
Every effort counts with a record-breaking 42,000 participants registering for the 17th edition of Malaysia’s premier distance running event.
Gleneagles MediCentre Opens in Hong Kong, Redefining Smart and Seamless Care
Step inside a new era of connected, technology-enabled care designed around patients’ needs.
.png?sfvrsn=3ba27871_1)
Celebrating the D.N.A. of Excellence across IHH Labs
The recent IHH Labs Townhall was especially meaningful as we celebrated the achievements of our medical technologists - the very backbone of IHH Laboratories - through the launch of the Global IHH Labs D.N.A. Award, which stands for Discovery, Nurturing, and Accuracy.
Gleneagles JPMC Partners Ministry of Health Brunei in Nation-wide Fight Against Non-communicable Diseases
Gleneagles JPMC is reinforcing its commitment to world-class cardiac care as part of Brunei’s whole-of-nation effort to combat non-communicable diseases.
